
Keywords: BAC; bronchioloalveolar carcinoma; BLTx; bilateral lung transplantation; BOS; bronchiolitis obliterans syndrome; CNIs; calcineurin inhibitors; COPD; chronic obstructive pulmonary disease; DFI; disease-free interval; LTx; lung transplantation; MMF; mycophe